Table 2.
Molecular prevalence of Bartonella spp and other canine vector borne pathogens
|
Study group |
Study population (N) |
Overall
Bartonella
spp prevalence N (%) |
BAPGM diagnostic platform |
Overall molecular prevalence of other CVBD pathogens N (%) |
Hemotropic
Mycoplasma
16S PCR |
Ehrlichia/Anaplasma
spp PCR |
SFG
Rickettsia
PCR |
Babesia
spp PCR |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Pre-enrichment PCR | Post-enrichment PCR | Isolate | ||||||||
| Group I |
47 |
9 (19%) |
Bk (3) |
Bh SA2 (2) |
0 |
3 (6%) |
Mhc (3) |
0 |
0 |
0 |
|
BhHI (1) |
Bspp. (2) |
|||||||||
|
Bspp. (1) | ||||||||||
| Group II |
50 |
10 (20%) |
Bvb III (1) |
Bvb II (1) |
Bvb II (8) |
3 (6%) |
Mhc (1) |
E. ewingii (2) |
0 |
0 |
| Group III |
21 |
2 (10%) |
Bvb I (1)
†
|
Bvb I (1)* |
Bvb I (1)* |
4 (19%) |
Mhc (1) |
E. ewingii (2) |
0 |
0 |
| Bvb I (1)* | C Mhp (1) | |||||||||
Legend:Bk – Bartonella koehlerae; BhSA2 – Bartonella henselae San Antonio 2; BhHI– Bartonella henselae Houston 1; Bvb – Bartonella vinsonii subsp berkhoffii genotypes I, II, & III; CVBD – Canine vector borne disease; † - Bvb genotype I DNA sequence amplified from serum; * - Bvb genotype I DNA sequence amplified from blood; Mhc – Mycoplasma hemocanis; C Mhp- Candidatus M. hematoparvum; Bspp – Bartonella spp; BAPGM – Bartonella Alpha Proteobacteria Growth Medium; PCR – Polymerase chain reaction; SFG – Spotted fever group.